Dean Investment Associates’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.18M | Buy |
62,447
+1,068
| +2% | +$78.1K | 0.55% | 94 |
|
|
2026
Q1 | $4.68M | Buy |
61,379
+8,771
| +17% | +$632K | 0.66% | 60 |
|
|
2025
Q4 | $3.36M | Sell |
52,608
-442
| -0.8% | -$27.2K | 0.48% | 107 |
|
|
2025
Q3 | $3.34M | Buy |
53,050
+13,537
| +34% | +$945K | 0.47% | 108 |
|
|
2025
Q2 | $2.95M | Buy |
+39,513
| New | +$3.1M | 0.43% | 115 |
|
|
2023
Q4 | – | Sell |
-22,771
| Closed | -$1.75M | – | 209 |
|
|
2023
Q3 | $1.75M | Buy |
22,771
+5,171
| +29% | +$429K | 0.29% | 146 |
|
|
2023
Q2 | $1.47M | Buy |
17,600
+2,307
| +15% | +$188K | 0.24% | 153 |
|
|
2023
Q1 | $1.29M | Buy |
15,293
+5,446
| +55% | +$468K | 0.21% | 170 |
|
|
2022
Q4 | $802K | Buy |
+9,847
| New | +$793K | 0.14% | 193 |
|
|
2022
Q2 | – | Sell |
-2,016
| Closed | -$226K | – | 229 |
|
|
2022
Q1 | $226K | Sell |
2,016
-181
| -8% | -$21.2K | 0.04% | 227 |
|
|
2021
Q4 | $266K | Sell |
2,197
-40
| -2% | -$4.45K | 0.05% | 229 |
|
|
2021
Q3 | $225K | Sell |
2,237
-1
| -0% | -$110 | 0.04% | 229 |
|
|
2021
Q2 | $261K | Sell |
2,238
-3,923
| -64% | -$471K | 0.05% | 229 |
|
|
2021
Q1 | $678K | Sell |
6,161
-19
| -0.3% | -$2.06K | 0.13% | 214 |
|
|
2020
Q4 | $620K | Sell |
6,180
-215
| -3% | -$19.9K | 0.13% | 217 |
|
|
2020
Q3 | $500K | Sell |
6,395
-122
| -2% | -$9.2K | 0.12% | 209 |
|
|
2020
Q2 | $454K | Sell |
6,517
-37
| -0.6% | -$2.33K | 0.11% | 206 |
|
|
2020
Q1 | $305K | Sell |
6,554
-13,154
| -67% | -$845K | 0.07% | 215 |
|
|
2019
Q4 | $1.56M | Sell |
19,708
-769
| -4% | -$59.1K | 0.24% | 150 |
|
|
2019
Q3 | $1.51M | Buy |
20,477
+1,991
| +11% | +$143K | 0.22% | 141 |
|
|
2019
Q2 | $1.44M | Buy |
18,486
+3,836
| +26% | +$291K | 0.21% | 142 |
|
|
2019
Q1 | $1.11M | Buy |
14,650
+282
| +2% | +$22.4K | 0.16% | 150 |
|
|
2018
Q4 | $1.05M | Buy |
14,368
+1,945
| +16% | +$155K | 0.17% | 146 |
|
|
2018
Q3 | $1.19M | Buy |
12,423
+55
| +0.4% | +$5.45K | 0.17% | 145 |
|
|
2018
Q2 | $1.24M | Sell |
12,368
-18
| -0.1% | -$1.9K | 0.18% | 138 |
|
|
2018
Q1 | $1.31M | Sell |
12,386
-4,324
| -26% | -$437K | 0.19% | 135 |
|
|
2017
Q4 | $1.55M | Sell |
16,710
-1,163
| -7% | -$106K | 0.24% | 139 |
|
|
2017
Q3 | $1.62M | Sell |
17,873
-1,732
| -9% | -$147K | 0.25% | 129 |
|
|
2017
Q2 | $1.65M | Sell |
19,605
-153
| -0.8% | -$12.3K | 0.25% | 126 |
|
|
2017
Q1 | $1.6M | Buy |
19,758
+360
| +2% | +$28.3K | 0.27% | 116 |
|
|
2016
Q4 | $1.46M | Sell |
19,398
-163
| -0.8% | -$11.8K | 0.25% | 114 |
|
|
2016
Q3 | $1.32M | Buy |
19,561
+1,140
| +6% | +$76.5K | 0.25% | 115 |
|
|
2016
Q2 | $1.25M | Sell |
18,421
-138
| -0.7% | -$10.1K | 0.24% | 112 |
|
|
2016
Q1 | $1.34M | Buy |
18,559
+13,924
| +300% | +$912K | 0.27% | 113 |
|
|
2015
Q4 | $313K | Buy |
+4,635
| New | +$324K | 0.07% | 206 |
|
|
2014
Q4 | – | Sell |
-5,490
| Closed | -$444K | – | 228 |
|
|
2014
Q3 | $444K | Sell |
5,490
-18
| -0.3% | -$1.5K | 0.11% | 195 |
|
|
2014
Q2 | $481K | Buy |
5,508
+475
| +9% | +$41.3K | 0.11% | 186 |
|
|
2014
Q1 | $434K | Buy |
5,033
+77
| +2% | +$6.31K | 0.1% | 190 |
|
|
2013
Q4 | $400K | Buy |
+4,956
| New | +$385K | 0.1% | 202 |
|
Other funds holding EMN
Dean Investment Associates's EMN Position: Q2 2026 in Review
Dean Investment Associates increased its Eastman Chemical (EMN) stake by 1.7% in Q2 2026, buying an estimated $78.1K and bringing the position to 62,447 shares worth $4.18M. The position accounts for 0.55% of the portfolio, ranked #94.
Dean Investment Associates first reported a position in EMN in Q4 2013 and has held it in 39 quarters since. The position peaked at $4.68M in Q1 2026. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.
- Dean Investment Associates held 62,447 shares of Eastman Chemical worth $4.18M as of Q2 2026.
- Dean Investment Associates bought 1,068 Eastman Chemical shares in Q2 2026, an estimated $78.1K.
- Eastman Chemical made up 0.55% of Dean Investment Associates's portfolio in Q2 2026, its #94 holding.
- Dean Investment Associates first reported a position in Eastman Chemical in Q4 2013 and has held it in 39 quarters since.
- Dean Investment Associates's Eastman Chemical position peaked at $4.68M in Q1 2026.
- 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.
Based on Dean Investment Associates's 13F filing for Q2 2026, filed 14 Aug 2026.